Evidence map›Paper›PMID 36968051›Full record

ArticleRSC advances2023

On-line pre-column FRAP-based antioxidant reaction coupled with HPLC-DAD-TOF/MS for rapid screening of natural antioxidants from different parts of

Zheng-Ming Qian, Xin-Jie Cheng, Qiao Wang, Qi Huang, Li-Ling Jin, Ya-Fei Ma, Jia-Sheng Xie, De-Qiang Li

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Novel Antioxidant Caffeate Esters of Black Locust (Plants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. The Flavonoid Extract ofAntioxidants (Basel, Switzerland) · 2025
    Article
  6. Korean Mistletoe (Antioxidants (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Revealing Medicinal Constituents ofMolecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zheng-Ming QianCollege of Medical Imaging Laboratory and Rehabilitation, Xiangnan University Chenzhou 423000 Hunan Province China.ORCID https://orcid.org/0000-0002-8467-2941
Xin-Jie ChengDepartment of Pharmacy, The Second Hospital of Hebei Medical University No. 215, Heping West Road Shijiazhuang 050000 Hebei Province China deqli@163.com.
Qiao WangDongguan HEC Cordyceps R&D Co., Ltd. No. 368, Zhen'an Middle Road, Chang'an Town Dongguan 523850 Guangdong Province China liqilingssz@163.com.
Qi HuangDongguan HEC Cordyceps R&D Co., Ltd. No. 368, Zhen'an Middle Road, Chang'an Town Dongguan 523850 Guangdong Province China liqilingssz@163.com.
Li-Ling JinDongguan HEC Cordyceps R&D Co., Ltd. No. 368, Zhen'an Middle Road, Chang'an Town Dongguan 523850 Guangdong Province China liqilingssz@163.com.
Ya-Fei MaDepartment of Pharmacy, The Second Hospital of Hebei Medical University No. 215, Heping West Road Shijiazhuang 050000 Hebei Province China deqli@163.com.
Jia-Sheng XieGuangdong Mige Sunshine Technology Co. Ltd. Guangzhou 510700 Guangdong Province China.
De-Qiang LiDepartment of Pharmacy, The Second Hospital of Hebei Medical University No. 215, Heping West Road Shijiazhuang 050000 Hebei Province China deqli@163.com.ORCID https://orcid.org/0000-0001-5255-6199
HEC Pharm (China) · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36968051
PMCPMC10035567
OpenAlexW4360783291

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.